Explore how combining BTK inhibitors with CAR T-cell therapy enhances treatment efficacy for B-cell malignancies while managing potential toxicities.
Jacqueline Dela Pena, PharmD, BCOP
Advertisement
Jacqueline Dela Pena, PharmD, BCOP
Memorial Sloan Kettering Cancer Center
Articles by Jacqueline Dela Pena, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bepirovirsen Shows Breakthrough Potential for Functional Cure in Chronic Hepatitis B
2
Lingering Muscle Damage After Weight Restoration in Anorexia Nervosa May Require Long-Term Care
3
Pharmacist-Led Dietary Guidance Supports Kidney Health
4
BTK Inhibitors with CAR T-cell Therapy
5